Dihydrosteffimycin compounds
    1.
    发明授权
    Dihydrosteffimycin compounds 失效
    二氢呋喃霉素化合物

    公开(公告)号:US4209611A

    公开(公告)日:1980-06-24

    申请号:US27878

    申请日:1979-04-06

    摘要: Antibiotics 10-dihydrosteffimycin (U-58,875), and 10-dihydrosteffimycin B (U-58,874) are produced by carbon 10 ketonic carbonyl reduction in fermentation processes using the known antibiotics steffimycin and steffimycin B, respectively, as starting materials. These novel antibiotics are active against various microorganisms, for example, Bacillus subtilis, Bacillus cereus, Sarcina lutea, Streptococcus pyogenes, and Mycobacterium avium. Thus, these antibiotics can be used to inhibit the growth of the above microorganisms in various environments.

    摘要翻译: 作为起始原料,使用已知的抗生素Steffimycin和steffimycin B作为起始原料,通过发酵过程中的碳10酮羰基还原制备了抗生素10-二氢去氧霉素(U-58,875)和10-二氢酪蛋白霉素B(U-58,874)。 这些新型抗生素对各种微生物具有活性,例如枯草芽孢杆菌,蜡状芽孢杆菌,黄连,链球菌和鸟分枝杆菌。 因此,这些抗生素可用于抑制各种环境中上述微生物的生长。

    Process for producing 10.dbd.dihydrosteffimycin and
10.dbd.dihydrosteffimycin B and microorganisms for producing same
    2.
    发明授权
    Process for producing 10.dbd.dihydrosteffimycin and 10.dbd.dihydrosteffimycin B and microorganisms for producing same 失效
    制备10 =二氢酪蛋白霉素和10 =二氢去氧霉素B的方法及其生产微生物

    公开(公告)号:US4264726A

    公开(公告)日:1981-04-28

    申请号:US129532

    申请日:1980-03-12

    摘要: Antibiotics 10-dihydrosteffimycin (U-58,875), and 10-dihydrosteffimycin B (U-58,874) are produced by carbon 10 ketonic carbonyl reduction in fermentation processes using the known antibiotics steffimycin and steffimycin B, respectively, as starting materials. These novel antibiotics are active against various microorganisms, for example, Bacillus subtilis, Bacillus cereus, Sarcina lutea, Streptococcus pyogenes, and Mycobacterium avium. Thus, these antibiotics can be used to inhibit the growth of the above microorganisms in various environments.

    摘要翻译: 作为起始原料,使用已知的抗生素Steffimycin和steffimycin B作为起始原料,通过发酵过程中的碳10酮羰基还原制备了抗生素10-二氢去氧霉素(U-58,875)和10-二氢酪蛋白霉素B(U-58,874)。 这些新型抗生素对各种微生物具有活性,例如枯草芽孢杆菌,蜡状芽孢杆菌,黄连,链球菌和鸟分枝杆菌。 因此,这些抗生素可用于抑制各种环境中上述微生物的生长。

    Process for preparing 7-deoxysteffimycinol
    3.
    发明授权
    Process for preparing 7-deoxysteffimycinol 失效
    制备7-脱氧硫嘧啶醇的方法

    公开(公告)号:US4116769A

    公开(公告)日:1978-09-26

    申请号:US851861

    申请日:1977-11-16

    IPC分类号: C12D9/20

    摘要: Bioconversion of the antibiotic steffimycinone to the antibiotic steffimycinol. Steffimycinol is active against various microorganisms, for example, Bacillus subtilis, Mycobacterium avium and Streptococcus pyogenes. Steffimycinol is converted to 7-deoxysteffimycinol by a microaerophilic Aeromonas hydrophila fermentation. 7-Deoxysteffimycinol is active against Sarcina lutea, Bacillus cereus, and B. subtilis. Thus, these antibiotics can be used to inhibit the growth of the above microorganisms in various environments.

    摘要翻译: 将抗生素Steffimycinone生物转化为抗生素steffimycinol。 Steffimycinol对各种微生物有活性,例如枯草芽孢杆菌,鸟分枝杆菌和化脓性链球菌。 通过微嗜酸气单胞菌嗜水气单胞菌发酵将Steffimycinol转化为7-脱氧硫嘧啶。 7-脱氧半胱氨酰霉素对黄体,蜡状芽孢杆菌和枯草芽孢杆菌具有活性。 因此,这些抗生素可用于抑制各种环境中上述微生物的生长。

    Process for producing steffimycinol
    4.
    发明授权
    Process for producing steffimycinol 失效
    辛伐他林生产工艺

    公开(公告)号:US4106994A

    公开(公告)日:1978-08-15

    申请号:US851866

    申请日:1977-11-16

    IPC分类号: C12D9/14

    摘要: Bioconversion of the antibiotic steffimycinone to the antibiotic steffimycinol. Steffimycinol is active against various microorganisms, for example, Bacillus subtilis, Mycobacterium avium and Streptococcus pyogenes. Steffimycinol is converted to 7-deoxysteffimycinol by a microaerophilic Aeromonas hydrophila fermentation. 7-Deoxysteffimycinol is active against Sarcina lutea, Bacillus cereus, and B. subtilis. Thus, these antibiotics can be used to inhibit the growth of the above microorganisms in various environments.

    摘要翻译: 将抗生素Steffimycinone生物转化为抗生素steffimycinol。 Steffimycinol对各种微生物有活性,例如枯草芽孢杆菌,鸟分枝杆菌和化脓性链球菌。 通过微嗜性嗜水气单胞菌嗜水气单胞菌发酵将Steffimycinol转化为7-脱氧硫嘧啶醇。 7-脱氧半胱氨酰霉素对黄体,蜡状芽孢杆菌和枯草芽孢杆菌具有活性。 因此,这些抗生素可用于抑制各种环境中上述微生物的生长。

    Process for preparing steffimycinol
    5.
    发明授权
    Process for preparing steffimycinol 失效
    制备Steffimycinol的方法

    公开(公告)号:US4077844A

    公开(公告)日:1978-03-07

    申请号:US782621

    申请日:1977-03-30

    IPC分类号: C12D9/18

    摘要: Bioconversion of the antibiotic steffimycinone to the antibiotic steffimycinol. Steffimycinol is active against various microorganisms, for example, Bacillus subtilis, Mycobacterium avium and Streptococcus pyogenes. Steffimycinol is converted to 7-deoxysteffimycinol by a microaerophilic Aeromonas hydrophila fermentation. 7-Deoxysteffimycinol is active against Sarcina lutea, Bacillus cereus, and B. subtilis. Thus, there antibiotics can be used to inhibit the growth of the above microorganisms in various environments.

    摘要翻译: 将抗生素Steffimycinone生物转化为抗生素steffimycinol。 Steffimycinol对各种微生物有活性,例如枯草芽孢杆菌,鸟分枝杆菌和化脓性链球菌。 通过微嗜酸气单胞菌嗜水气单胞菌发酵将Steffimycinol转化为7-脱氧硫嘧啶。 7-脱氧半胱氨酰霉素对黄体,蜡状芽孢杆菌和枯草芽孢杆菌具有活性。 因此,可以使用抗生素来抑制各种环境中的上述微生物的生长。

    Nobamycin its analogs and process therefore
    6.
    发明授权
    Nobamycin its analogs and process therefore 失效
    因此,它的类似物和方法是Nobamycin

    公开(公告)号:US4767847A

    公开(公告)日:1988-08-30

    申请号:US262019

    申请日:1981-05-11

    CPC分类号: C07H15/252

    摘要: The invention concerns a novel nogamycin having a heretofore unknown configuration and novel analogs which are active against various microorganisms. The invention also includes novel methods of making substituted and unsubstituted nogamycin having an essentially pure isomeric form of a preferred configuration.

    摘要翻译: 本发明涉及一种具有迄今为止未知构型的新型诺加霉素和对各种微生物有活性的新型类似物。 本发明还包括制备取代和未取代的具有基本上纯的异构体形式的优素构型的新霉素的新方法。

    Antibiotic 273.sub.a1
    7.
    发明授权
    Antibiotic 273.sub.a1 失效
    抗生素273a1

    公开(公告)号:US4505895A

    公开(公告)日:1985-03-19

    申请号:US480604

    申请日:1983-03-30

    CPC分类号: C12P1/06

    摘要: Novel and useful antibiotics designated 273a.sub.1.spsb..alpha. and 273a.sub.1.spsb..beta. can be produced in a fermentation using Streptomyces paulus, strain 273, NRRL 12251. These antibiotics are active against various Gram-positive bacteria. Also, these antibiotics are, advantageously, soluble in aqueous solutions.

    摘要翻译: 在使用链霉菌(Streptomyces paulus),菌株273,NRRL 12251的发酵中可以产生名为273a1α和273a1β的新型和有用的抗生素。这些抗生素对各种革兰氏阳性细菌具有活性。 而且,这些抗生素有利地可溶于水溶液。

    Nogalamycin derivatives
    8.
    发明授权
    Nogalamycin derivatives 失效
    诺卡拉霉素衍生物

    公开(公告)号:US4439602A

    公开(公告)日:1984-03-27

    申请号:US294655

    申请日:1981-08-20

    申请人: Paul F. Wiley

    发明人: Paul F. Wiley

    IPC分类号: C07H15/252 C07H15/26

    CPC分类号: C07H15/252

    摘要: Novel N-demethyl derivatives of nogalamycin and process for preparing the same. The compounds of this invention are active against various microorganisms.

    摘要翻译: 新诺莫霉素的N-去甲基衍生物及其制备方法。 本发明的化合物对各种微生物具有活性。

    Antibiotics steffimycinol and 7-deoxysteffimycinol and process for
preparing the same
    9.
    发明授权
    Antibiotics steffimycinol and 7-deoxysteffimycinol and process for preparing the same 失效
    抗生素steffimycinol和7-脱氧硫嘧啶醇及其制备方法

    公开(公告)号:US4089872A

    公开(公告)日:1978-05-16

    申请号:US775856

    申请日:1977-03-09

    IPC分类号: C07C49/72

    CPC分类号: C07C46/00 Y10S514/924

    摘要: Antibiotics steffimycinol and 7-deoxysteffimycinol produced by reduction of the antibiotic steffimycinone. Steffimycinol is active against various microorganisms, for example, Bacillus subtilis, Mycobacterium avium and Streptococcus pyogenes; 7-deoxysteffimycinol is active against Sarcina lutea, Bacillus cereus, and B. subtilis. Thus, these antibiotics can be used to inhibit the growth of the above microorganisms in various environments.

    摘要翻译: 通过还原抗生素Steffimycinone产生的抗生素steffimycinol和7-脱氧头孢霉素。 Steffimycinol对各种微生物有活性,例如枯草芽孢杆菌,鸟分枝杆菌和化脓性链球菌; 7-脱氧硫嘧啶醇对黄曲霉,蜡状芽孢杆菌和枯草芽孢杆菌具有活性。 因此,这些抗生素可用于抑制各种环境中上述微生物的生长。

    Nogamycin and process of preparation
    10.
    发明授权
    Nogamycin and process of preparation 失效
    诺加霉素及其制备方法

    公开(公告)号:US4064340A

    公开(公告)日:1977-12-20

    申请号:US748717

    申请日:1976-12-09

    CPC分类号: C07H15/252

    摘要: Novel antibiotic, nogamycin (U-51,204) prepared chemically from nogalamycinic acid. Nogamycin is active against various microorganisms, for example, Mycobacterium avium, Bacillus subtilis, Lactobacillus casei, Staphylococcus aureus, and Sarcina lutea. Thus, nogamycin can be used to inhibit the growth of the above microorganisms in various environments.

    摘要翻译: 新霉素,诺卡霉素(U-51,204)由诺加霉素酸化学制备。 诺卡霉素对各种微生物有活性,例如,鸟分枝杆菌,枯草芽孢杆菌,干酪乳杆菌,金黄色葡萄球菌和黄褐斑。 因此,诺可霉素可用于抑制各种环境中上述微生物的生长。